Infinity Pharma (INFI) Sees FY13 Loss of $115M - $125M; Issues Ops Update

January 7, 2013 8:03 AM EST Send to a Friend
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its anticipated pipeline goals and provided financial guidance for 2013. In the first ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login